```html

Jaundice‑Induced Itch (Pruritus)

What is Jaundice‑Induced Itch?

Jaundice‑induced itch, medically known as cholestatic pruritus, is an unpleasant, often intense sensation that makes a person want to scratch. It occurs when the skin is exposed to high levels of bile salts, bilirubin, or other substances that accumulate in the bloodstream because the liver is not able to excrete them properly. The itching typically starts on the palms, soles, and trunk, and can spread to the entire body. While the itch itself is a skin symptom, it signals an underlying problem with the liver or biliary system.

Because the condition is directly linked to the presence of jaundice (yellowing of the skin and eyes), patients often notice the discoloration first, followed by the itch. The symptom can be distressing, interfere with sleep, and lower quality of life.

Common Causes

Any disease that obstructs bile flow (cholestasis) or damages liver cells can lead to jaundice‑induced itch. The most frequent culprits are:

• Primary biliary cholangitis (PBC) – an autoimmune disease that slowly destroys small bile ducts.
• Primary sclerosing cholangitis (PSC) – inflammation and scarring of the larger bile ducts, often associated with ulcerative colitis.
• Gallstones – can block the common bile duct, causing a sudden rise in bilirubin.
• Choledochal cysts – congenital dilations of bile ducts that predispose to stasis.
• Benign biliary strictures – scarring from prior surgery, infection, or trauma.
• Hepatitis (viral, alcoholic, drug‑induced) – liver inflammation impairs bilirubin processing.
• Drug‑induced cholestasis – e.g., oral contraceptives, certain antibiotics (e.g., erythromycin), statins, and chemotherapy agents.
• Liver tumors (hepatocellular carcinoma, cholangiocarcinoma) – obstruct bile flow mechanically.
• Genetic disorders – such as progressive familial intrahepatic cholestasis (PFIC) and biliary atresia in infants.
• Pregnancy‑related cholestasis – occurs in the third trimester and resolves after delivery.

Associated Symptoms

Patients with cholestatic itch often notice other signs of liver dysfunction:

• Yellowing of the skin and sclera (jaundice)
• Dark urine and pale stools
• Fatigue and weakness
• Abdominal discomfort, especially in the right upper quadrant
• Unexplained weight loss
• Swelling of the abdomen or legs (ascites, edema)
• Fever and chills if infection is present
• Easy bruising or bleeding due to reduced clotting factors
• Confusion or memory problems (hepatic encephalopathy) in advanced disease

When to See a Doctor

While occasional mild itch is common, seek medical attention promptly if you experience any of the following:

• New or worsening jaundice (yellow skin/eyes)
• Itch that interferes with sleep or daily activities
• Persistent dark urine or clay‑colored stools
• Abdominal pain, especially if severe or localized
• Unexplained fever, chills, or nausea/vomiting
• Swelling of the abdomen, legs, or face
• Bleeding gums, easy bruising, or prolonged nosebleeds
• Any change in mental status (confusion, drowsiness)

Early evaluation can identify reversible causes (e.g., gallstone blockage) and prevent progression to chronic liver disease.

Diagnosis

Doctors use a combination of history, physical exam, laboratory tests, and imaging to pinpoint the cause of cholestatic itch.

1. Medical History & Physical Exam

• Onset, duration, and pattern of itch and jaundice
• Medication and supplement review (many drugs cause cholestasis)
• Alcohol use, travel history, family history of liver disease
• Skin exam for scratching marks, excoriations, and distribution of jaundice

2. Laboratory Tests

• Liver function panel – elevated alkaline phosphatase (ALP) and gamma‑glutamyl transferase (GGT) suggest cholestasis; elevated bilirubin confirms jaundice.
• Serum aminotransferases (AST/ALT) – to assess hepatocellular injury.
• Complete blood count (CBC) – looks for anemia, infection, or platelet abnormalities.
• Coagulation profile (PT/INR) – evaluates synthetic liver function.
• Autoimmune markers (AMA, ANA, anti‑SM) – screen for PBC or autoimmune hepatitis.
• Viral hepatitis serologies (HBV, HCV) – rule out viral causes.

3. Imaging Studies

• Ultrasound – first‑line for gallstones, bile duct dilation, liver texture.
• Magnetic Resonance Cholangiopancreatography (MRCP) – detailed view of intra‑ and extra‑hepatic ducts; excellent for PSC.
• CT scan – assesses masses, vascular anatomy, and complications.
• Endoscopic Retrograde Cholangiopancreatography (ERCP) – diagnostic and therapeutic (can remove stones or place stents).

4. Specialized Tests

• Serum bile acid levels – markedly elevated in cholestatic pruritus.
• Liver biopsy – sometimes required to confirm autoimmune or infiltrative diseases.

Treatment Options

Treatment focuses on two goals: addressing the underlying liver/biliary problem and relieving the itch.

1. Treat the Underlying Cause

• Gallstone obstruction – ERCP with sphincterotomy or surgical removal.
• Primary biliary cholangitis – ursodeoxycholic acid (UDCA) is first‑line; obeticholic acid for UDCA‑non‑responders.
• Primary sclerosing cholangitis – no cure; management includes antibiotics for cholangitis, endoscopic dilation, and eventual liver transplantation.
• Drug‑induced cholestasis – discontinue the offending medication under physician guidance.
• Liver cancer or tumors – surgical resection, locoregional therapy, or transplant when appropriate.
• Pregnancy‑related cholestasis – ursodeoxycholic acid and early delivery if fetal risk rises.

2. Symptomatic Relief of Itch

• First‑line agents
  • Cholestyramine (a bile‑acid sequestrant) – 4 g PO 1–4 times daily; take with water and separate from other meds.
  • Rifampicin – 150 mg PO twice daily; also reduces bile‑acid synthesis.
• Second‑line / adjunctive agents
  • Serotonin reuptake inhibitors (e.g., sertraline 50 mg daily) – useful especially when depression co‑exists.
  • Olopatadine or hydroxyzine – antihistamines can help if there is a histamine component.
  • Topical therapies – cool compresses, menthol or camphor creams, colloidal oatmeal baths.
• Advanced options
  • Glycopyrrolate (anticholinergic) or nalfurafine (κ‑opioid receptor agonist) – approved in Japan, increasingly used off‑label.
  • Plasmapheresis – reserved for refractory cases, especially in acute liver failure.

3. Lifestyle & Home Measures

• Keep nails short and smooth to minimize skin damage from scratching.
• Use mild, fragrance‑free soaps and lukewarm water; avoid hot showers which can worsen itch.
• Apply emollients (e.g., 5% urea cream) immediately after bathing.
• Wear loose‑fitting, breathable cotton clothing.
• Stay well‑hydrated – adequate fluid intake supports bile flow.
• Limit alcohol and avoid hepatotoxic substances.

Prevention Tips

While some causes (genetic diseases) cannot be prevented, many risk factors are modifiable:

• Maintain a healthy weight and limit alcohol consumption to reduce fatty liver disease.
• Take prescribed medications exactly as directed; discuss alternative drugs with your physician if you develop liver‑related symptoms.
• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to prevent viral hepatitis.
• Seek prompt care for gallstone symptoms (right‑upper‑quadrant pain, nausea) to avoid prolonged obstruction.
• During pregnancy, report any new itching or yellowing to your obstetrician early.

Emergency Warning Signs

Key Take‑aways

Jaundice‑induced itch is more than a nuisance; it is a clinical clue that the liver’s ability to process bile is compromised. Prompt evaluation, identification of the underlying cause, and targeted therapy can relieve the itch, protect liver function, and prevent serious complications. Always consult a healthcare professional when new jaundice or persistent pruritus occurs, especially if accompanied by abdominal pain, fever, or changes in mental status.

---

References:

• Mayo Clinic. “Pruritus (Itching) – Causes, Symptoms, and Treatments.” 2023.
• American Liver Foundation. “Cholestatic Itching.” Updated 2022.
• European Association for the Study of the Liver (EASL). “Guidelines on the Diagnosis and Treatment of Primary Biliary Cholangitis.” 2021.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Liver Disease Diagnosis.” 2022.
• World Health Organization. “Viral Hepatitis Fact Sheet.” 2023.

```